Two aspiring medical marijuana companies have filed lawsuits against the Pennsylvania Department of Health over its medical cannabis licensing process. And one of them is seeking to take the permit awarded to another licensed grower/processor after its parent company was implicated in a criminal investigation.
In their petitions, filed Sept. 8 in the Commonwealth Court, BrightStar BioMedics and Keystone ReLeaf allege that the permitting process used by the department’s Office of Medical Marijuana was lacking transparency and did not provide an adequate avenue for appeals.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
